Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on curr ...

AFTER “fighting a losing battle” with her weight for years, a mum shed 11st in a matter months with the help of weight loss ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

A NEW potential side effect of ‘Ozempic-style’ fat jabs has been discovered, putting experts on edge. The injections have allegedly helped celebs like Sun columnist Jeremy ...